Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shenpu Penyanke Granules for Chronic Pelvic Pain Sequelae of PID
CTR20221449Phase 3Completed
- Sponsor
- Jiangsu Kanion Pharmaceutical Co., Ltd.
- Start
- Jun 2022
- Countries
- 1
01
Overview
A Phase 3 trial of Shenpu Penyanke Granules in chronic prostatitis (CP), sponsored by Jiangsu Kanion Pharmaceutical Co., Ltd.. Started Jun 2022; status: completed.
02
Drugs
Shenpu Penyanke Granules
03
Conditions
chronic prostatitis (CP)
Beyond the preview
Go deeper on CTR20221449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20221449.